Merck (MRK) is in talks to purchase Revolution Medicines (RVBD) for about $30 billion. Shares of Revolution Medicines jumped 11%. A deal for the cancer-drug biotech could come as soon as later this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results